YU70804A - Controlled release oxycodone compositions - Google Patents

Controlled release oxycodone compositions

Info

Publication number
YU70804A
YU70804A YU70804A YU70804A YU70804A YU 70804 A YU70804 A YU 70804A YU 70804 A YU70804 A YU 70804A YU 70804 A YU70804 A YU 70804A YU 70804 A YU70804 A YU 70804A
Authority
YU
Yugoslavia
Prior art keywords
mass
controlled release
hours
oxycodone
released
Prior art date
Application number
YU70804A
Other languages
Serbo-Croatian (sh)
Inventor
Benjamin Oshlack
Mark Chasin
John Joseph Minogue
Robert Francis Kaiko
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of YU70804A publication Critical patent/YU70804A/en
Publication of RS50053B publication Critical patent/RS50053B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invention relates to a solid form of dosage with controlled release to apply orally, containing analgetically efficient quantity of oxycodone or some of the salts thereof in a matrix case, where the speed of solution release form in vitro measured in so called USP Paddle method at 100 -1 in 900 ml water solution of buffer stop (pH between 1,6 and 7,2) at 37°C between 12,5 and 42,5 % (mass) oxycodone released upon one hour, between 25 and 55 % (mass) oxydocone released upon 2 hours, between 45 and 75% (mass) oxycodone released upon 4 hours, and between 55 and 85 % (mass) oxycodone released upon 6 hours, where the release speed in vitro is actually independent of pH when pH is between 1,6 and 7,2. That form of dosage is achieved in the form of a pill. The invention herewith relates to the procedure for preparation of such an orally form of controlled release.
YUP-708/04A 1992-11-25 1993-05-21 OXYCODONOUS CONTROLLED DISPOSALS RS50053B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21014692A 1992-11-25 1992-11-25

Publications (2)

Publication Number Publication Date
YU70804A true YU70804A (en) 2005-11-28
RS50053B RS50053B (en) 2008-11-28

Family

ID=47559778

Family Applications (3)

Application Number Title Priority Date Filing Date
YU20050408A YU20050408A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
YU20050409A YU20050409A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
YU20050410A YU20050410A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions

Family Applications Before (3)

Application Number Title Priority Date Filing Date
YU20050408A YU20050408A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
YU20050409A YU20050409A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
YU20050410A YU20050410A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions

Country Status (2)

Country Link
RS (1) RS50053B (en)
YU (3) YU20050408A (en)

Also Published As

Publication number Publication date
YU20050408A (en) 2006-05-25
YU20050409A (en) 2006-05-25
YU20050410A (en) 2006-05-25
RS50053B (en) 2008-11-28

Similar Documents

Publication Publication Date Title
AU7407387A (en) Controlled release dihydrocodeine composition
GB2196848B (en) Controlled release hydromorphone composition
YU35893A (en) CONTROLLED-RELEASE OXIDON FORMULATIONS AND THEIR USE
EP0149920A3 (en) Pharmaceutical formulation
IL117356A (en) Controlled release matrix and pharmaceutical compositions for oral administration containing it
RU2005115855A (en) COMPOSITION OF TRAMADOL PROLONGED BY RELEASE WITH 24 HOUR ACTION
EP1026157A3 (en) Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
AU2377588A (en) Controlled absorption diltiazem formulations
FI955837A (en) Process for the preparation of an orally administrable solid dosage form containing diclofenac
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
YU70804A (en) Controlled release oxycodone compositions
NZ217778A (en) Antiinflammatory compositions containing piroxicam
EP0256507A3 (en) 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmaceutical compositions containing the compound
YU20050413A (en) Controlled release oxycodone compositions
CA2052532A1 (en) Hardening agent for affected tissues of the digestive system